NCT06604923
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment. No drug interventions Not Available Not Available active_not_recruiting NCT06610695
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals No drug interventions Not Available Not Available enrolling_by_invitation NCT04510090
Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus No drug interventions treatment 1 completed NCT01073202
Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation treatment Not Available completed NCT00007033
Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease treatment Not Available completed NCT02370251
Compassionate Use of Omegaven in Children treatment 2 / 3 completed NCT02922751
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) No drug interventions Not Available Not Available completed NCT00392977
Brain Manganese Deposition in High Risk Neonates No drug interventions Not Available Not Available completed NCT02778698
Compassionate Use of Omegaven No drug interventions Not Available Not Available approved_for_marketing NCT02780193
Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury Not Available Not Available approved_for_marketing NCT01062815
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants No drug interventions prevention Not Available terminated NCT00004315
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease treatment 2 unknown_status NCT04604652
Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis No drug interventions treatment 2 completed NCT05718349
FGF19 in Obstructive Cholestasis: "Unveil the Signal" No drug interventions Not Available Not Available recruiting NCT00080236
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation treatment 2 completed NCT02966834
Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis treatment 2 completed NCT04167358
Linerixibat Long-term Safety, and Tolerability Study treatment 3 recruiting NCT00816348
Compassionate Use of Omegaven IV Fat Emulsion treatment 2 terminated NCT02767648
Inter-regional Cohort of Neonatal and Infant Cholestasis in the Greater Southwest Region No drug interventions Not Available Not Available terminated NCT02412566
SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury Not Available Not Available available NCT03337074
Paternally Inherited Phenotypes in Cholestasis No drug interventions Not Available Not Available unknown_status NCT00826020
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis treatment 2 completed NCT00007020
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid treatment 3 completed NCT01998620
Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis treatment 4 unknown_status NCT03662282
Omegaven as Alternative Parenteral Fat Nutrition treatment 3 completed NCT04309773
Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy treatment 3 recruiting NCT00512629
Cholestasis Prevention: Efficacy of IV Fish Oil prevention 1 completed NCT00135044
A Trial of Taurine Supplementation in Parenteral Nutrition 1 No drug interventions prevention Not Available unknown_status NCT06005701
Mallampati Score for Prediction and Prognosis of Postoperative Mortality and Morbidity and Safety Profiles of Patients Undergoing Laparoscopic Cholecystectomy in Qassim Region No drug interventions Not Available Not Available active_not_recruiting NCT00738101
Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants treatment Not Available completed NCT02148146
Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis Not Available Not Available no_longer_available NCT03992014
Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat treatment 1 completed NCT01252043
Retrospective Review of CT and MR in Pediatric Patients With Cholestasis No drug interventions Not Available Not Available unknown_status NCT00058890
Gabapentin to Treat Itch in Patients With Liver Disease treatment 3 completed NCT01297933
Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease Not Available Not Available approved_for_marketing NCT02663453
Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition treatment 3 completed NCT02721277
SMOFlipid to Lessen the Severity of Neonatal Cholestasis supportive_care 1 / 2 terminated NCT05582447
Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease No drug interventions Not Available Not Available active_not_recruiting NCT02477345
Compassionate Use of Omegaven IV Fat Emulsion Not Available Not Available no_longer_available NCT02334293
Omegaven® as Parenteral Nutrition treatment Not Available unknown_status NCT01164878
Cholestasis in Extreme Low Birth Weight Infants (ELBW) No drug interventions Not Available Not Available completed NCT02267707
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia treatment 1 terminated NCT00969332
A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease treatment 2 terminated NCT01173159
Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis treatment Not Available completed NCT01373918
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders prevention 4 terminated NCT01739517
Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease treatment 2 unknown_status NCT02420496
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants treatment 2 withdrawn NCT02936596
Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome treatment Not Available unknown_status NCT01879735
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT basic_science 1 completed NCT01585935
Preventing Cholestasis Using SMOFLipid® prevention 4 completed NCT00846963
Ursodiol for Treating Parenteral Nutrition Associated Cholestasis in Neonates treatment 2 / 3 completed NCT01194063
Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children treatment 3 completed NCT00685386
A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP) No drug interventions supportive_care Not Available completed NCT00392730
Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children No drug interventions Not Available Not Available completed NCT02357576
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD prevention 3 completed NCT01683240
Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones No drug interventions treatment Not Available completed NCT03072667
Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease Not Available Not Available approved_for_marketing NCT06364969
Investigation of the Pruritogens of Liver-related Diseases No drug interventions Not Available Not Available not_yet_recruiting NCT01247012
Minimization of IntraLipid Versus Omegaven No drug interventions treatment 2 / 3 unknown_status NCT00004410
Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants treatment Not Available completed NCT02801981
Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers No drug interventions treatment 1 completed NCT00004414
Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis treatment Not Available completed NCT04053023
Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects treatment 1 completed NCT02917408
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital No drug interventions Not Available Not Available completed